Lipocalin-2 Upregulation in Nasopharyngeal Carcinoma: A Novel Potential Diagnostic Biomarker

BACKGROUND: Lipocalin-2 (LCN2) deregulation has been reported in several types of cancer and is implicated in the proliferation, migration, angiogenesis, and progression of tumors. However, its aberrant expression has been rarely studied in nasopharyngeal carcinoma (NPC). In the present study, we in...

Descripción completa

Detalles Bibliográficos
Autores principales: Jani Kargar Moghaddam, Saghi, Mohammadi Roushandeh, Amaneh, Hamidi, Masoud, Nemati, Shadman, Jahanian-Najafabadi, Ali, Habibi Roudkenar, Mehryar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Shiraz University of Medical Sciences 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10542929/
https://www.ncbi.nlm.nih.gov/pubmed/37791335
http://dx.doi.org/10.30476/IJMS.2022.93041.2452

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10542929/
https://www.ncbi.nlm.nih.gov/pubmed/37791335
http://dx.doi.org/10.30476/IJMS.2022.93041.2452

Ejemplares similares